Company intelligence / Profile preview

Ossa Therapeutics

West Lafayette, Indiana, USA

Ownership: Private
Development stage: Other

Overview

Ossa Therapeutics is a biotechnology company specializing in the development of bone-targeted therapeutic agents designed to treat bone metastases and other skeletal disorders. The company utilizes a proprietary drug delivery platform that conjugates therapeutic payloads to bone-homing ligands, ensuring high concentrations of the drug are delivered directly to the bone tissue. This targeted approach is intended to enhance therapeutic potency while minimizing off-target effects and systemic toxicity. Ossa's research pipeline includes small molecule inhibitors and agonists focused on oncology and regenerative medicine.

Therapeutic areas: OncologyRheumatology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

salubrinal

Unknown

Partnerships

Purdue University

Beyond the preview

Go deeper on Ossa Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ossa Therapeutics.

Explore the full profile